Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraemar Shipping Regulatory News (BMS)

Share Price Information for Braemar Shipping (BMS)

Share Price is delayed by 15 minutes
Get Live Data
238.00    1.50 (0.63%)
Bid:
235.00
Ask:
238.00
Spread: 3.00 (1.277%)
Market Cap: £76.13m
BMS Live PriceLast checked at - London Stock Exchange

Intraday Braemar Shipping Share Chart

HY25 Trading Update

19 Sep 2024 07:00

RNS Number : 7740E
Braemar PLC
19 September 2024
 

 

 

 

 

 

 

 

  19 September 2024

 

 

BRAEMAR PLC

("Braemar" or the "Company" or the "Group")

 

HY25 Trading Update

Trading in line with expectations

 

Braemar Plc (LSE: BMS), a leading provider of expert investment, chartering, and risk management advice to the shipping and energy markets, today announces an update on trading for the six months ended 31 August 2024.

 

Trading Update

The board is pleased to announce that the Group has continued to trade well and in line with expectations1.

 

Revenue for HY25 is expected to be not less than £75m (HY24: £74.9m), with underlying operating profit (before acquisition-related expenditure) slightly ahead of the prior year (HY24: £7.6m).

 

The Group has continued to maintain a positive cash position with increased net cash of £3.3m at the end of the period (HY24: £3.1m; FY24: £1.0m).

 

Outlook

The board remains confident in the outlook for the remainder of the financial year and beyond, as the Group continues to benefit from its increasingly resilient and focused growth strategy. The total forward orderbook2 continues to be strong and at the end of August 2024 was $80.9m (HY24: $67.2, FY24: $82.6m).

 

Notice of results

The Group expects to announce its HY25 results for the six months ended 31 August 2024 by mid November 2024.

 

1. Company compiled consensus as at the date of this announcement: FY25 revenue of £153.2m and FY25 underlying operating profit (before acquisition-related expenditure) of £18.1m

2. The total forward order book covers revenue that will be earned in future periods up until 2039

 

ENDS 

For further information, contact:

Braemar Plc

James Gundy, Group Chief Executive Officer

Tel +44 (0) 20 3142 4100

Grant Foley, Group Chief Financial Officer

Rebecca-Joy Wekwete, Company Secretary

Canaccord Genuity

 

Adam James / Harry Rees

 

 

Tel +44 (0) 20 7523 8000

Burson Buchanan

Charles Ryland / Stephanie Whitmore / Jack Devoy / Abby Gilchrist

Tel +44 (0) 20 7466 5000

 

Notes to Editors:

 

About Braemar Plc

Braemar provides expert investment, chartering, and risk management advice that enable its clients to secure sustainable returns and mitigate risk in the volatile world of shipping and energy. Our experienced brokers work in tandem with specialist professionals to form teams tailored to our customers' needs, and provide an integrated service supported by a collaborative culture.

 

Braemar joined the Official List of the London Stock Exchange in November 1997 and trades under the symbol BMS.

 

For more information, including our investor presentation, visit www.Braemar.com and follow Braemar on LinkedIn.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTLPMPTMTMBBJI
Date   Source Headline
10th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20252:47 pmRNSGrant of Share Incentives to PDMRs
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20254:15 pmRNSDirector/PDMR Shareholding
2nd Jul 20254:07 pmRNSResults of 2025 Annual General Meeting
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:01 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 202511:11 amRNSInvestigation Update
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20251:42 pmRNSNotice of 2025 Annual General Meeting
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20254:50 pmRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:01 amRNSCommencement of Share Buyback Programme
29th May 20257:00 amRNSFY25 Final Results
20th May 202510:00 amRNS-RInvestor Presentation at Mello London
15th May 20257:00 amRNSNotice of FY25 Results
2nd May 202512:14 pmRNSTotal Voting Rights
1st Apr 20253:43 pmRNSTotal Voting Rights
24th Mar 20257:00 amRNSFY25 Trading Update
7th Mar 20257:00 amRNSDirectorate Change
28th Feb 20259:04 amRNSTotal Voting Rights
31st Jan 20253:14 pmRNSTotal Voting Rights
31st Dec 20247:00 amRNSTotal Voting Rights
17th Dec 202410:23 amRNSHolding(s) in Company
10th Dec 20244:48 pmRNSHolding(s) in Company
10th Dec 20244:13 pmRNSDirector/PDMR Shareholding
3rd Dec 20249:27 amRNSTotal Voting Rights
28th Nov 20244:17 pmRNSPDMR Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.